Well good luck with that healthy! Will be happy to have a conversation with you after listing.
Bones track record will have nothing to do with it as Callahan and crew will soon make their mark. Outside demand for the stock remains positive.
Market cap of peers eg mxc of over 40 mil, auger well for botanix and on top of that they have the point of difference in permatrex.
Will certainly be an interesting resisting.
Ann: Prospectus - Botanix Pharmaceuticals-BNE.AX, page-22
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
-0.010(2.99%) |
Mkt cap ! $590.6M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 33.8¢ | 31.5¢ | $1.933M | 5.941M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 261016 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 125980 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |